Wegovy (Semaglutide Injection) Wegovy is a once-weekly semaglutide injection that mimics the GLP-1 hormone, helping regulate appetite and food intake
And these drugs carry their own side effect profile nausea, gastrointestinal issues, and in rare cases more serious complications that need to be weighed carefully
Approved and late-stage GLP-1 and incretin drugs (2026) Combination and multi-receptor mechanisms What distinguishes the modern pipeline is not just more of the same receptor but a widening menu of mechanisms
It doesn't just work in a petri dish
USD 39.95 Prices may be subject to local taxes which are calculated during checkout Similar content being viewed by others Change history 11 May 2026 A Correction to this paper has been published: References Kreutz, R
Your provider will check in with you at each dose increase to assess tolerability, discuss any side effects, and confirm that you're ready to move further